Dr. Reddy's Laboratories Limited has informed the Exchange about change in Management
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories has announced internal changes to its senior management team, effective April 1, 2026. Mr. M S Madhu Sundar, currently Head of Global Manufacturing for Oral Solid Dosages and Operational Excellence, will be elevated to Global Head of Quality and Pharmacovigilance and inducted into the Management Council. He has 28 years of industrial experience and has been with the company since 2017. Separately, revised roles/designations have been assigned to four other senior managers: Mr. M V Ramana as CEO Global Generics, Mr. Sanjay Sharma as Chief Operating Officer, Mr. Krishna Venkatesh as Global Head of IPDO (Integrated Product Development), and Mr. Patrick Aghanian as Head of Consumer Health Organization.
This is a routine internal management restructuring with no external hires or resignations, suggesting continuity in leadership and likely no immediate material impact on the stock price.